Results 171 to 180 of about 5,470,649 (304)

Expanding the molecular spectrum of tenosynovial giant cell tumors. [PDF]

Front Oncol, 2022
Gauduchon T, Vanacker H, Pissaloux D, Cassier P, Dufresne A, Karanian M, Meurgey A, Bouhamama A, Gouin F, Ray-Coquard I, Blay JY, Tirode F, Brahmi M.   +12 more
europepmc   +1 more source

Scalp Dysesthesia: Emerging Pathophysiologic Insights and Therapeutic Implications

International Journal of Dermatology, EarlyView.
Scalp dysesthesia is a chronic condition diagnosed through exclusion. This scoping review synthesized data from 59 patients to identify recurrent clinical features, comorbidities, and management strategies that may support earlier diagnosis. Emerging patterns suggest that neuronal sensitization may underlie common symptoms.
Aditya K. Gupta, Jaspreet Kaur, Amanda Liddy, Paradi Mirmirani, Vincent Piguet   +4 more
wiley   +1 more source

Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants. [PDF]

J Bone Oncol
Verspoor FGM, Krebbekx GGJ, Duivenvoorden MJC, Sumathi V, Evans S.   +4 more
europepmc   +1 more source

T2-star (T2*)-weighted magnetic resonance imaging of tenosynovial giant cell tumors. [PDF]

Eur J Radiol Open, 2023
Sakamoto A, Noguchi T, Matsuda S.
europepmc   +1 more source

ICSH Guidance on Bone Marrow Examination and Reporting

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Examination of the bone marrow (BM) remains fundamental to the diagnosis, classification, prognostication, and monitoring of hematolymphoid and other disorders affecting blood cell production. Since publication of the International Council for Standardization in Haematology (ICSH) guideline in 2008, advances in diagnostic technologies, disease
Wendy N. Erber, Alexandar Tzankov, Olga Pozdnyakova, Hiromichi Matsushita, Gina Zini, Leonie Saft, on behalf of the International Council for Standardization in Haematology   +6 more
wiley   +1 more source

A New Relevant Integrated Radiologic and Surgical Classification Scheme for Giant Cell Tumors of Bones. [PDF]

J Am Acad Orthop Surg Glob Res Rev
Chang YC, Pretell-Mazzini J, Temple HT, Soler R, Purrinos J, Rosenberg AE, Jonczak E, Subhawong TK.   +7 more
europepmc   +1 more source

Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors. [PDF]

Clin Cancer Res, 2022
van IJzendoorn DGP, Matusiak M, Charville GW, Spierenburg G, Varma S, Colburg DRC, van de Sande MAJ, van Langevelde K, Mohler DG, Ganjoo KN, Bui NQ, Avedian RS, Bovée JVMG, Steffner R, West RB, van de Rijn M.   +15 more
europepmc   +1 more source

Hypophosphataemia in adults: approach to diagnosis and management

Internal Medicine Journal, EarlyView.
Abstract Hypophosphataemia is a common electrolyte disorder which can have clinically significant consequences for bone, muscle, neurological and haematological function. Its causes range from transient transcellular shifts in hospitalised patients to chronic renal phosphate‐wasting disorders mediated by fibroblast growth factor 23 (FGF23).
Kajanan Parameshwaran, Mawson Wang, Kirtan Ganda   +2 more
wiley   +1 more source

Correction: Postsurgery fluids promote transition of cancer stem cell toendothelial and AKT/mTOR activity contributing to relapse of giant cell tumors of bone. [PDF]

Oncotarget
Fazioli F, Colella G, Miceli R, Salvatore MGD, Gallo M, Boccella S, Chiara A, Ruosi C, Nigris F.   +8 more
europepmc   +1 more source

PD-L1 Status in Tenosynovial Giant Cell Tumors. [PDF]

Medicina (Kaunas), 2022
Zenginkinet T, Faruq AU, Toksoz Yildirim AN, Iyetin Y, Ozturan B, Okay E, Celik A, Ozkan K, Akyurek M.   +8 more
europepmc   +1 more source